Reply to M. Gleeson et al.
Mayo Clinic, Rochester, MN nowakowski.grzegorz@mayo.edu.
Grzegorz S
GS
Nowakowski
Mayo Clinic, Rochester, MN.
William R
WR
Macon
British Colombia Cancer Research Centre, Vancouver, British Columbia, Canada.
Randy D
RD
Gascoyne
Mayo Clinic, Rochester, MN.
Thomas E
TE
Witzig
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use*; D016403:Lymphoma, Large B-Cell, Diffuse / Q000188:drug therapy*; D008297:Male; D013792:Thalidomide / Q000031:analogs & derivatives*
D007155:Immunologic Factors; D013792:Thalidomide